If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
627.00    2.00 (0.32%)
Bid:
626.00
Ask:
628.00
Spread: 2.00 (0.319%)
Market Cap: £506.89m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

28 Sep 2009 15:36

RNS Number : 7845Z
Bloomsbury Publishing PLC
28 September 2009
 



For immediate release 28th September 2009

Bloomsbury Publishing Plc

("Bloomsbury" or "the Company")

Notification of Interests of Directors and Persons Discharging Managerial Responsibility ("PDMR") and connected persons

Bloomsbury announces the following changes to the interests of Directors and PDMRs in the Company's ordinary shares of 1.25p each ("Shares").

On 25 September 2009 the Company made the following awards of Shares ("Awards") under the Bloomsbury Performance Share Plan 2005 ("PSP"):

Executive Directors

Name

Role

PSP Award (number)

Total PSP Awards 

(including current award) 

Beneficial interest in shares (number excluding Awards)

Nigel Newton

Chief Executive

235,820

610,810

2,258,488

Colin Adams

Group Finance Director

117,189

282,778

50,000

Richard Charkin

Executive Director

169,189

465,037

12,000

The total number of Shares awarded to Executive Directors under the PSP is equal to 1.84 % of the issued share capital of the Company.

The Executive Directors have a total beneficial interest (excluding PSP Awards) in 3.15% of the issued share capital of the Company.

PDMRs

Name

PSP Award (number)

Total Awards

(including current award)

Kathy Rooney

45,278

144,181

Jill Coleman 

52,446

204,393

Jonathan Glasspool

39,220

74,907

Awards granted under the PSP will vest on 25th September 2012, but only to the extent that certain performance criteria based on earnings per share growth and total shareholder return are satisfied by the Company over a three year performance period. No consideration is payable for the grant of the Awards and the receipt of Shares is conditional upon meeting the performance criteria. It is intended that the Company's employee benefit trust will acquire shares (either by way of subscription for new shares, market purchase or from treasury) necessary to fulfil any obligation arising from the vesting of the Awards.

The notification of these Awards is intended to satisfy the Company's obligations under Disclosure Rule 3.1.4.

Ian Portal

Group Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDCSXDGGCI
Date   Source Headline
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report
2nd Jun 202311:50 amRNSDirector/PDMR Shareholding
1st Jun 20239:34 amRNSDirector Declaration
31st May 20232:04 pmRNSInvestor Presentation
31st May 20237:00 amRNSAudited Preliminary Results
16th May 20237:00 amRNSNotice of Capital Markets Event
2nd May 20232:43 pmRNSNotice of Results
12th Apr 20233:16 pmRNSHolding(s) in Company
11th Apr 202310:03 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSTrading Update
1st Mar 20237:00 amRNSNotice of Trading Update
17th Feb 20232:09 pmRNSBLOCK LISTING SIX MONTHLY RETURN
11th Jan 20239:08 amRNSHolding(s) in Company
18th Nov 20222:29 pmRNSHolding(s) in Company
14th Nov 20225:16 pmRNSHolding(s) in Company
2nd Nov 20222:56 pmRNSDirector/PDMR Shareholding
1st Nov 20225:16 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSInvestor Presentation
27th Oct 20221:02 pmEQSBloomsbury Publishing pleased with 'surge in the numbers'
26th Oct 20227:00 amRNSUnaudited Interim Results
14th Oct 202212:41 pmRNSHolding(s) in Company
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Sep 202211:16 amRNSHolding(s) in Company
24th Aug 20225:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20224:16 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSBlock Listing Six Monthly Return
10th Aug 20225:22 pmRNSDirector/PDMR Shareholding
29th Jul 20225:25 pmRNSHolding(s) in Company
20th Jul 20224:32 pmRNSResults of the 2022 Annual General Meeting
20th Jul 20227:00 amRNSAGM Trading Update
4th Jul 20223:52 pmRNSNotice of AGM Clarification
1st Jul 20227:00 amRNSBloomsbury wins Small Cap Award
28th Jun 20224:42 pmRNSAnnual Financial Report
15th Jun 20227:00 amRNSAudited Preliminary Results
25th May 202210:50 amRNSDirector Declaration
24th May 20227:00 amRNSNotice of Results
26th Apr 20224:22 pmRNSHolding(s) in Company
25th Apr 202211:52 amRNSHolding(s) in Company
22nd Apr 20222:12 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSTrading Update
11th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Feb 20222:50 pmRNSBlock Listing Six Monthly Return
26th Jan 20227:00 amRNSTrading Update
19th Jan 20225:45 pmRNSHolding(s) in Company
16th Dec 20217:00 amRNSAcquisition
27th Oct 20217:00 amRNSUnaudited Interim Results
27th Oct 20217:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.